GE HealthCare Technologies (GEHC) Net Income towards Common Stockholders (2022 - 2026)
GE HealthCare Technologies' (GEHC) quarterly Net Income towards Common Stockholders came in at $574.0 million in Q2 2026, up 14.8% YoY from $500.0 million in Q2 2025, and up 39.66% on a QoQ basis from $411.0 million in Q1 2026.
GE HealthCare Technologies (GEHC) Net Income towards Common Stockholders (2022 - 2026) Analysis & Trends
GE HealthCare Technologies (GEHC) has 5 years of Net Income towards Common Stockholders data on file, last reported at $574.0 million in Q2 2026.
- Quarterly Net Income towards Common Stockholders rose 14.8% year-over-year to $574.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $2.1 billion (down 10.0% YoY) and the FY2025 annual result came in at $2.1 billion, up 4.57% from the prior year.
- Net Income towards Common Stockholders climbed to $574.0 million in Q2 2026, from $411.0 million in the prior quarter.
- In the past five years, Net Income towards Common Stockholders ranged from a high of $721.0 million in Q4 2024 to a low of $189.0 million in Q1 2023.
- A 5-year average of $468.4 million and a median of $467.0 million in 2024 frame the typical range for Net Income towards Common Stockholders.
- Annual changes were most pronounced in 2023 — Net Income towards Common Stockholders tumbled 51.41% — and 2024, when it soared 97.88%.
- Tracing GEHC's Net Income towards Common Stockholders over 5 years: stood at $554.0 million in 2022, then fell by 27.26% to $403.0 million in 2023, then jumped by 78.91% to $721.0 million in 2024, then decreased by 16.5% to $602.0 million in 2025, then slipped by 4.65% to $574.0 million in 2026.
- The last three Net Income towards Common Stockholders figures came in at $574.0 million (Q2 2026), $411.0 million (Q1 2026), and $602.0 million (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.54 Bn | 193.94 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 129.61 Bn | 126.14 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 120.10 Bn | 110.88 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn | 907.00 Mn |
| 5 | Edwards Lifesciences | 52.52 Bn | 48.27 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.69 Bn | 32.75 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.78 Bn | 31.68 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | 621.86 Mn |
| 9 | Steris | 23.09 Bn | 22.61 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Zimmer Biomet Holdings | 19.37 Bn | 18.96 Bn | 1.54 Bn | 199.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 574.00 Mn |
| Mar 31, 2026 | 411.00 Mn |
| Dec 31, 2025 | 602.00 Mn |
| Sep 30, 2025 | 464.00 Mn |
| Jun 30, 2025 | 500.00 Mn |
| Mar 31, 2025 | 588.00 Mn |
| Dec 31, 2024 | 721.00 Mn |
| Sep 30, 2024 | 470.00 Mn |
| Jun 30, 2024 | 428.00 Mn |
| Mar 31, 2024 | 374.00 Mn |
| Dec 31, 2023 | 403.00 Mn |
| Sep 30, 2023 | 375.00 Mn |
| Jun 30, 2023 | 418.00 Mn |
| Mar 31, 2023 | 189.00 Mn |
| Dec 31, 2022 | 554.00 Mn |
| Sep 30, 2022 | 487.00 Mn |
| Jun 30, 2022 | 485.00 Mn |
| Mar 31, 2022 | 389.00 Mn |